home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Clinical Trial Site Burden & Clinical Research Associate Burnout — How Studies Suffer

 
  June 21, 2023  
     
 
Xtalks, online
2023 -8-01


Study timelines take huge hits from industry turnover. A site can stop enrolling when a clinical research coordinator leaves, and a study can fall behind when a clinical research associate (CRA) leaves. But is industry churn really just an unavoidable byproduct of tight labor market conditions? Or is it self-inflicted pain from cumbersome study processes? This webinar will talk about how cumbersome, outdated and inefficient processes create unnecessary work for both sites and CRAs, leading to clinical trial site burden, burnout and churn.
 
Site study teams struggle with learning how to execute complex protocols without automation, juggling multiple logins, double entering source data into an eCRF and managing disparate query streams from CRAs and data management teams.
 
CRAs struggle with punishing travel schedules and workloads, the challenge of force-fitting large amounts of Source Data Review and Verification into an eight-hour onsite day, filing trip reports and constantly flagging and re-educating sites on avoidable quality issues.
 
If these processes can be transformed into a single, streamlined process using a site-based, protocol-driven eSource platform that integrates into the eCRF, CRAs would see drastically reduced workloads and lowered clinical trial site burden. They could focus on the most important study priorities such as patient recruitment, retention, protocol compliance and patient safety. Instead of being at odds with each other, the site and CRA can collaborate more effectively, with each focusing on their respective strengths.
 
Join this webinar for this candid, thought-provoking and solution-oriented examination of the current clinical trial process, its impact on sites, especially with regard to clinical trial site burden, and CROs and the transformative potential of technology.
 
 
Organized by: Xtalks
Invited Speakers: Raymond Nomizu, CEO, CRIO Dr. Marcus Stone, Principal, The Spine Network Dr. Chardae Rodgers-Gamble, CEO and owner, CR Clinical
 
Deadline for Abstracts: 2023 -8-01
 
Registration: Free registration
E-mail: ajuurinen@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.